Check out Eric Padron's talk at the Approaches to Drug Development for Rare Malignancies session at #AACR26! Read a recent article Dr. Padron co-authored on MYST acetyltransferases as a targetable therapeutic vulnerability in SETBP1-mutant leukemia.
https://
aacrjournals.org/bloodcancerdis
cov/article/doi/10.1158/2643-3230.BCD-25-0446
…